Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

CAO Chang, WEN Xiaoli, LIN Wenhua, LI Yang, SHI Tao. Analysis on 2 621 cases of adverse drug reaction reports by Fishbone and Pareto diagram[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(1): 88-92. doi: 10.3969/j.issn.1006-0111.2018.01.019
Citation: CHEN Yanhong, WANG Jingxia, TAO Xia, CHEN Wansheng, WU Rong. Application of FMEA regulated drug supply chain collaborative service platform for drug-receiving in outpatient pharmacy[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(1): 86-90. doi: 10.3969/j.issn.1006-0111.2019.01.020

Application of FMEA regulated drug supply chain collaborative service platform for drug-receiving in outpatient pharmacy

doi: 10.3969/j.issn.1006-0111.2019.01.020
  • Received Date: 2018-05-08
  • Rev Recd Date: 2018-10-25
  • Objective To strengthen the system of drug supply chain collaborative service platform in drug supply, decrease drug inventory backlog, and improve the outpatient pharmacy management capacity in outpatient pharmacy. Methods Failure mode and effects analysis(FMEA) method was used to discover the potential risks in the drug supply chain collaborative service platform and formulate the corresponding improvement measures. Results The number of drug-receiving errors dropped from 137 times to 32 times and the risk reduction rate was 76.64% after improving the procurement process of the supply chain service platform, which significantly reduced the risk of contracting errors. Conclusion FMEA method could help to figure out the loopholes and hidden dangers of the pharmacy system, which made the outpatient pharmacy more reasonable and accurate by constantly improving the measures of the drug supply chain collaborative service platform.
  • [1] 陈莉华,黄齐慧,成明建,等.基于精益思想的医院领药业务流程再造[J].中国民族民间医药,2012,15(2):159-160.
    [2] 李惠莹,云雄.供应链协同服务平台系统在医院药库中的应用[J].医药导报,2014,33(10):1398-1340.
    [3] 沈烽,张健,杨传敏,等.我院药库物流信息化管理实践及体会[J].中国药房,2009,20(31):2429-2431.
    [4] 周玲,缪丽燕.院内供应链药品采购模式对改善我院药品库存管理探讨[J].中国药房,2011,22(9):821.
    [5] 马瑛,庞成森,王新鹏.完善医院药品供应链与优化库存结构的实践与体会[J].医药导报,2013,24(21):1969.
    [6] 庞成森,董海燕,董亚琳.基于互联网的药品供应链协同平台在我院药库的应用[J].中国药师,2014,17(4):682-684.
    [7] SAE J. Potential failure mode and effects analysis in design (Design FMEA) potential failure mode and effects analysis in manufacturing and assembly processes (Process FMEA),and potential failure mode and effects analysis for machinery (Machinery FMEA)[S].2002.
    [8] SAE ARP5580.Recommended failure modes and effects analysis (FMEA) practices for non-automobile applications[S].2001.
    [9] BS EN60812:2006 Analysis techniques for system reliability,procedures for failure mode and effect analysis (FMEA)[S].2006.
    [10] 于雁玲,武建康,范慧霞.失效模式后果分析在高危药品管理中的应用[J].中国药物与临床,2013,11:1503-1504.
    [11] ONODERA K.Effective techniques of FMEA at each life-cycle stage[A],Proceedings,Annual Reliability and Maintain-ability Symposium[C].IEEE,1997.
    [12] 武志昂.试论药品风险管理和质量价值链[j].中国药物评价,2012,29(2):180-182.
    [13] ASHLEY L,ARMITAGE G.Failure mode and effects analysis:an empirical comparison of failure mode scoring procedures[J].J Patient Saf,2010,6(4):210-215.
    [14] 宋相梅,曲建华,王莉梅,等.运用FMEA法规范住院药房麻醉药品及一类精神药品质量管理[J].中国药物评价,2017,34(2):153-156.
    [15] 梁婉宁,赵育鹏,廖志斌.计算门诊药房二级库药品库存上下限的方法分析[J].中国医学创新,2017,14(10):140-143.
    [16] WU M,SIN A,NISHIOKA F,et al.Non-drug costa associated with outpatient infliximab administration in pediatric inflammatory bowel disease[J].Inflammatory Bowel Diseases,2013,19(7):1514-1517.
    [17] 贾俊琴,宋沧桑,包金颖. PDCA循环在病区药品管理持续改进中的应用[J].中国药物评价,2016,33(4)::251-252.
    [18] 宋菲,董迪,甄健存.风险管理在胰岛素及其类似物用药错误防范中的应用[J].药学实践杂志,2017,37(7):650-653.
    [19] PONTO T,ISMAIL N I,ABDUL MAJEED A B,et al.A prospective study on the pattern of medication use for schizophrenia in the outpatient pharmacy department,Hospital Tengku Ampuan Rahimah,Selangor,Malaysia[J].Methods Find Exp Clin Pharmacol,2010,32(6):427-432.
    [20] JAGER N G,ROSING H,SCHELLENS J H,et al. Tamoxifen dose and serum concentrations of tamoxifen and six of its metabolites in routine clinical outpatient care[J].Breast Cancer Res Treat,2014,143(3):477-483.
    [21] KUO G M,TOUCHETTE D R,MARINAC J S.Drug errors and related interventions reported by United States clinical pharmacists:the American College of Clinical Pharmacy practice-based research network medication error detection,amelioration and prevention study[J].Pharmacotherapy,2013,33(3):253-265.
    [22] BAO L,WANG Y,SHANG T,et al.A novel clinical pharmacy management system in improving the rational drug use in department of general surgery[J].Indian J Pharm Sci,2013,75(1):11-15.
    [23] YEH M L,CHANG Y J,YEH S J,et al.Potential drug-drug interactions in pediatric outpatient prescriptions for newborns and infants[J].Computer Methods and Programs in Biomedicine,2014,113(1):15-22.
  • 加载中
  • Cited by

    Periodical cited type(33)

    1. 邱蕾. 帕累托图与鱼骨图分析法在基层医院药剂科中成药合理用药中的应用. 中医药管理杂志. 2023(08): 106-109 .
    2. 赵静,韩凤昭. 质量管理工具在人血白蛋白管理中的运用. 中国处方药. 2023(06): 63-66 .
    3. 顾嘉伟. 帕累托图联合鱼骨图分析法在中成药用药改进中的应用. 中医药管理杂志. 2023(15): 102-104 .
    4. 李鑫,张敬一,孙雪. 硝酸酯类药物致不良反应/事件的帕累托分析. 实用药物与临床. 2023(10): 913-917 .
    5. 王馨,陈醒,王兴东,吴波,骆雨璇. 490例药品不良反应报告的临床分析. 医学研究与战创伤救治. 2023(06): 623-627 .
    6. 刘淑仪,丁晓磊. 校园共享电动车出行风险因素及防范研究——以华南A大学为例. 物流工程与管理. 2023(11): 170-173 .
    7. 周杨,任常谕,巫思琼. 2012-2019年我院严重药品不良反应帕累托图分析. 临床合理用药杂志. 2022(01): 164-166 .
    8. 曾贝贝,金超超,余之焕,叶昌兆. 抗肿瘤药物不良反应的Pareto最优分析. 中国社区医师. 2022(09): 3-5 .
    9. 邱永军,汪芳,邱在军. 先兆流产或先兆早产患者初次应用硫酸镁注射液的药品不良反应预测模型研究. 实用临床医药杂志. 2022(09): 63-67 .
    10. 翁国娣,莫家乐,林晓柔. 800张消化内科门诊中成药处方用药合理性与管理建议. 中医药管理杂志. 2022(14): 123-125 .
    11. 罗琪,徐喆,杨欢,汪洋. 先兆流产或先兆早产患者应用硫酸镁注射液的不良反应预测模型. 中国实验诊断学. 2022(08): 1180-1182 .
    12. 潘青杰,张文文,王芳. 羁押人员应用抗感染药物所致的158例不良反应分析. 药学实践杂志. 2021(01): 90-93 .
    13. 袁月玲,张芬,孟晓君,张红梅. 2017-2020年本院368例药物不良反应分析. 中国医学创新. 2021(21): 98-101 .
    14. 刘苑. 帕累托图及鱼骨图分析法在基层医疗机构合理用药管理中的应用. 中国医药指南. 2021(28): 10-12 .
    15. 杨丽雄,蔡丽秋. 某院2019年抗肿瘤药销售金额的帕累托图分析. 海峡药学. 2021(10): 159-161 .
    16. 吕楠,杨帅,田欢,张炜华,吴筱菁,王巧玲,岳宝森. 应用帕累托法分析我院436例药品不良反应报告. 中国医药导刊. 2021(11): 843-847 .
    17. 余玖霞,戎立保. 基于散点图、帕累托图及鱼骨图分析354例药品不良反应情况. 中医临床研究. 2021(36): 142-146 .
    18. 黄莹,刘飞,孔玲娟,赵颉. 质量管理工具对412例药品不良反应报告的分析. 临床合理用药杂志. 2020(03): 165-167 .
    19. 卫峻琦,施芳红,李浩,沈安乐,张顺国. 高风险注射制剂标识方式的帕累托法则分析及标准化研究. 中国药业. 2020(06): 61-63 .
    20. 常渭娟,常便利,陈静. 鱼骨图分析法对乳腺癌患者术后功能锻炼依从性的影响. 临床医学研究与实践. 2020(05): 168-170 .
    21. 吉建,张虹,吕艳艳. 帕累托图及鱼骨图分析法在管理中成药合理用药中的应用. 中国中医药信息杂志. 2020(04): 129-132 .
    22. 吕艳艳,张虹,吉建. 持续改进门诊老年病人镇痛药处方在质量管理中的作用. 安徽医药. 2020(04): 795-799 .
    23. 陈华漫,黄红萍. 药师进行临床督导常见问题的帕累托图-鱼骨图分析. 海峡药学. 2020(05): 231-234 .
    24. 吕天益,匡丽,陈明颖. 1073例热毒宁注射液临床用药帕累托图及鱼骨图分析. 中国药物警戒. 2020(10): 745-748 .
    25. 刘祚汝. PDCA管理模式在规范基层医院中药注射剂使用中的应用研究. 陕西中医药大学学报. 2019(01): 64-68 .
    26. 陈月,鲁戈,孙楚枫,封宇飞. 21468例药物咨询的帕累托图分析. 中国医院用药评价与分析. 2019(02): 246-247+250 .
    27. 王泽洪. PDCA循环在检验科危急值管理中的应用效果. 临床医学研究与实践. 2019(17): 183-184+187 .
    28. 车凤莲,易燕桃,黄小瑜. 我院2016~2018年369例药品不良反应分析. 北方药学. 2019(09): 164-165 .
    29. 韩丽珍. PDCA循环法应用前后肿瘤科病案缺陷状况对比分析. 中国卫生统计. 2019(05): 745-747 .
    30. 曹畅,刘岳金,曾玉兰,钟凯龙,王路敏,曾娜婷,叶岩荣. 我院2018年度门诊不合理抗菌药物处方的帕累托法分析. 中国药物应用与监测. 2019(05): 302-304 .
    31. 童文珍,尹俊英,许俊华,郭霞,郑立新. 鱼骨柏拉图分析法在消毒供应中心医院感染管控中应用的效果. 中华医院感染学杂志. 2019(22): 3506-3510 .
    32. 郭姣丽,覃春英,房子胜,李金桔,樊敏. 我院2013~2018年521例药物不良反应报告分析. 海峡药学. 2019(11): 253-255 .
    33. 程晓珍,夏碧珍. 抗感染药物对肿瘤患者内科治疗的临床效果分析. 中华肿瘤防治杂志. 2019(S1): 145+147 .

    Other cited types(2)

通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(4004) PDF downloads(447) Cited by(35)

Related
Proportional views

Application of FMEA regulated drug supply chain collaborative service platform for drug-receiving in outpatient pharmacy

doi: 10.3969/j.issn.1006-0111.2019.01.020

Abstract: Objective To strengthen the system of drug supply chain collaborative service platform in drug supply, decrease drug inventory backlog, and improve the outpatient pharmacy management capacity in outpatient pharmacy. Methods Failure mode and effects analysis(FMEA) method was used to discover the potential risks in the drug supply chain collaborative service platform and formulate the corresponding improvement measures. Results The number of drug-receiving errors dropped from 137 times to 32 times and the risk reduction rate was 76.64% after improving the procurement process of the supply chain service platform, which significantly reduced the risk of contracting errors. Conclusion FMEA method could help to figure out the loopholes and hidden dangers of the pharmacy system, which made the outpatient pharmacy more reasonable and accurate by constantly improving the measures of the drug supply chain collaborative service platform.

CAO Chang, WEN Xiaoli, LIN Wenhua, LI Yang, SHI Tao. Analysis on 2 621 cases of adverse drug reaction reports by Fishbone and Pareto diagram[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(1): 88-92. doi: 10.3969/j.issn.1006-0111.2018.01.019
Citation: CHEN Yanhong, WANG Jingxia, TAO Xia, CHEN Wansheng, WU Rong. Application of FMEA regulated drug supply chain collaborative service platform for drug-receiving in outpatient pharmacy[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(1): 86-90. doi: 10.3969/j.issn.1006-0111.2019.01.020
Reference (23)

Catalog

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return